Dr. James W. Rocco, MD, PhD

Dr. Rocco practices at OSU Eye and Ear Institute in Columbus, Ohio.

Dr. Rocco's NPI, 1972594091, was assigned on October 31, 2005. Dr. Rocco graduated from Icahn School of Medicine at Mount Sinai in 1994. Dr. Rocco holds Ohio license 35125186.

Dr. Rocco's primary practice is OSU Eye and Ear Institute, at 460 W 10th Ave, Columbus, OH 43210 in Franklin County. The practice phone is (614) 366-3687.

Dr. Rocco's primary practice is OSU Eye and Ear Institute in Columbus, Ohio. Dr. Rocco is also affiliated with Ohio State University Hospital. The medical group on file is OSU Otolaryngology Head & Neck Surgery. Dmand AI also links Dr. Rocco to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rocco practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Rocco's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Dr. Rocco's licenses on file in 2 states: Ohio and Massachusetts.

CMS data shows 169 Medicare services from Dr. Rocco across 3 procedure codes in 2024, for 115 Medicare patients. Medicare paid $8,632 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 115 Medicare patients who saw Dr. Rocco in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rocco's median patient age at 69, with 32% women.

Dr. Rocco accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 103 papers to Dr. Rocco, published from 2010 to 2025. 2023 was the busiest year, with 9. The most frequent topics are Head and Neck Neoplasms, Squamous Cell Carcinoma of Head and Neck and Carcinoma, Squamous Cell. Dr. Rocco has published most often in Oral Oncol. Dr. Rocco's most frequent co-authors are Matthew Owen Old, MD, Stephen Y. Kang, MD and Ricardo L. Carrau, MD.

Dmand AI links Dr. Rocco to 4 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Lymphoid Interstitial Pneumonia, Neoplasms, Squamous Cell and Oropharyngeal Neoplasms.

CMS Open Payments shows 54 general payments to Dr. Rocco from 6 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $11,332.

Dr. Rocco graduated from Icahn School of Medicine at Mount Sinai in 1994.